An Upcoming Clinical Study to Measure the Safety and Impact of a Drug Called Macitentan in Teenage and Adult Fontan Patients.

Clinical trial NCT03775421 · TERMINATED

Trial details

NCT number: NCT03775421
Sponsor: Actelion
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Congenital Heart Disease With Fontan Circulation

Start date: 2019-04-11
Primary completion: 2022-01-18
Enrollment: 112

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.